UNIVERSI
TÄ
TS-
BIBLIOTHEK
P
ADERBORN
Anmelden
Menü
Menü
Start
Hilfe
Blog
Weitere Dienste
Neuerwerbungslisten
Fachsystematik Bücher
Erwerbungsvorschlag
Bestellung aus dem Magazin
Fernleihe
Einstellungen
Sprache
Deutsch
Deutsch
Englisch
Farbschema
Hell
Dunkel
Automatisch
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist
gegebenenfalls
nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
Universitätsbibliothek
Katalog
Suche
Details
Zur Ergebnisliste
Ergebnis 13 von 40
Datensatz exportieren als...
BibTeX
Statin Use and Survival with Early-Stage Hepatocellular Carcinoma
Cancer epidemiology, biomarkers & prevention, 2016-04, Vol.25 (4), p.686-692
Jeon, Christie Y
Goodman, Marc T
Cook-Wiens, Galen
Sundaram, Vinay
2016
Details
Autor(en) / Beteiligte
Jeon, Christie Y
Goodman, Marc T
Cook-Wiens, Galen
Sundaram, Vinay
Titel
Statin Use and Survival with Early-Stage Hepatocellular Carcinoma
Ist Teil von
Cancer epidemiology, biomarkers & prevention, 2016-04, Vol.25 (4), p.686-692
Ort / Verlag
United States
Erscheinungsjahr
2016
Link zum Volltext
Quelle
MEDLINE
Beschreibungen/Notizen
Limited clinical and epidemiologic data suggest that statins may improve the outcomes of hepatocellular carcinoma (HCC), which has poor prognosis. We identified 1,036 stage I or II HCC patients, diagnosed between 2007 and 2009, through the linked Surveillance, Epidemiology, and End Results (SEER) Program and Medicare claims database. Of these, 363 patients were using statin either at the time of their HCC diagnosis or afterwards. We conducted multivariable Cox regression analysis to estimate the time-dependent effect of statin on survival. The analysis included age, sex, resection, transarterial chemoembolization, transplantation, cirrhosis, cardiovascular disease, diabetes, dyslipidemia, and hepatitis B and C. Over a median follow-up time of 21 months, 584 HCC patients died. Statin users had a longer median survival compared with nonusers: 23.9 versus 18.9 months (P = 0.047). However, after accounting for immortal time bias and confounding, statin use was not associated with survival (HR, 0.98; 95% confidence interval, 0.80-1.20). The associations did not vary by hepatitis C or intensity of statin use. Statin treatment after HCC diagnosis was not associated with survival in elderly patients with stage I/II disease. Our study of nationally representative elderly patients with stage I or II HCC in the United States shows that statin treatment does not improve survival with liver cancer. Cancer Epidemiol Biomarkers Prev; 25(4); 686-92. ©2016 AACR.
Sprache
Englisch
Identifikatoren
ISSN: 1055-9965
eISSN: 1538-7755
DOI: 10.1158/1055-9965.EPI-15-1040
Titel-ID: cdi_proquest_miscellaneous_1790467763
Format
–
Schlagworte
Aged
,
Aged, 80 and over
,
Carcinoma, Hepatocellular - drug therapy
,
Carcinoma, Hepatocellular - mortality
,
Cohort Studies
,
Female
,
Humans
,
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
,
Male
,
Neoplasm Staging
,
Retrospective Studies
,
Survival Analysis
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von
bX